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Abstract
Background: A German cohort study on 1,528 carbon black production workers estimated an elevated lung
cancer SMR ranging from 1.8-2.2 depending on the reference population. No positive trends with carbon black
exposures were noted in the analyses. A nested case control study, however, identified smoking and previous
exposures to known carcinogens, such as crystalline silica, received prior to work in the carbon black industry as
important risk factors.
We used a Bayesian procedure to adjust the SMR, based on a prior of seven independent parameter distributions
describing smoking behaviour and crystalline silica dust exposure (as indicator of a group of correlated carcinogen
exposures received previously) in the cohort and population as well as the strength of the relationship of these
factors with lung cancer mortality. We implemented the approach by Markov Chain Monte Carlo Methods (MCMC)
programmed in R, a statistical computing system freely available on the internet, and we provide the program
code.
Results: When putting a flat prior to the SMR a Markov chain of length 1,000,000 returned a median posterior SMR
estimate (that is, the adjusted SMR) in the range between 1.32 (95% posterior interval: 0.7, 2.1) and 1.00 (0.2, 3.3)
depending on the method of assessing previous exposures.
Conclusions: Bayesian bias adjustment is an excellent tool to effectively combine data about confounders from
different sources. The usually calculated lung cancer SMR statistic in a cohort of carbon black workers
overestimated effect and precision when compared with the Bayesian results. Quantitative bias adjustment should
become a regular tool in occupational epidemiology to address narrative discussions of potential distortions.
Background
Carbon black is a powdered form of elemental carbon
that is manufactured by the controlled vapor-phase pyr-
olysis of hydrocarbons. Preferential raw materials for
most carbon black production processes are feedstock
oils that contain a high content of aromatic hydrocar-
bons. Over 90% of the world’s carbon black production
is used for the reinforcement of rubber; about two
thirds are used for tires and one third for the produc-
tion of technical rubber articles.
Car tires contain approximately 30% to 35% of carbon
blacks of different types. The remaining world produc-
tion of carbon black is used for printing inks, colours
and lacquers, stabilizers for synthetics, and in the electri-
cal industry [1]. Currently, greater than 95% of worldwide
carbon black production is via the oil furnace black pro-
cess [2]. Different grades of carbon black are typically
produced by using different reactor designs and by vary-
ing the reactor temperatures and/or residence times [3].
The most recent evaluation of possible human cancer
risks due to carbon black exposure was performed by an
IARC (International Agency for Research on Cancer)
Working Group in February 2006 [4]. The Working
Group identified lung cancer as the most important
endpoint to consider and exposures to workers at car-
bon black production sites as the most relevant for an
evaluation of risk. The group concluded that the human
evidence for carcinogenicity was inadequate.( I A R C ,
overall Group 2B).
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German investigation of 1,528 carbon black production
workers[5-7]. Based on 50 observed cases a lung cancer
SMR (standardized mortality ratio) of 2.18 (0.95-CI:
1.61, 2.87; national reference rates from West Germany;
CI = confidence interval) or 1.83 (0.95-CI: 1.34, 2.39;
state reference rates from North-Rhine Westphalia) was
estimated. Positive trends with carbon black exposures
were not observed in internal dose-response analyses
[6,7]. However, a nested case-control study [8] identified
smoking and previous exposures to known carcinogens
prior to work at the carbon black plant as important
risk factors. Due to correlations between previous expo-
sures to carcinogens, crystalline silica exposure was used
as a surrogate for the group of occupational confoun-
ders experienced prior to work at the carbon black
plant (see Büchte and co-workers [8] for details). A sim-
ple sensitivity analysis concluded that these two factors
(smoking and previous exposures) may explain the
major part of the excess risk in lung cancer reported in
the original cohort analysis [5]. The IARC working
group raised concerns as to whether the simple sensitiv-
ity analysis was appropriate for adjustment since the
findings were difficult to interpret. We thus now present
results from a Bayesian bias adjustment that addresses
deficiencies of the simple sensitivity analysis.
Customarily, confidence intervals estimate random
error, not other sources of uncertainty, such as con-
founding, selection bias and measurement error. To
address this additional uncertainty of an effect measure
simple sensitivity analyses, Monte Carlo sensitivity ana-
lyses (Probability Sensitivity Analyses) or Bayesian ana-
lyses can be used - but Bayesian analyses appear to
come with the stronger rationale because the only for-
mal statistical interpretation available for Monte Carlo
simulation approaches is Bayesian [9,10]. In addition,
practical advantages exist when the analyst follows the
Bayesian approach [11]. In retrospective mortality stu-
dies, such as the German carbon black cohort described
above, informationo ns m o k i n ga n dp r e v i o u se x p o s u r e s
is either lacking or incomplete. By including the limited
information available on smoking and previous expo-
sures from a case-control study [8] in a Bayesian frame-
work quantitative estimates of the uncertainty of the
SMR as a result of confounding can be determined. We
use the carbon black example to apply and illustrate this
method. Details of the procedure and explanations of
the Bayesian approach are given in the Methods section.
We implemented the approach by Markov Chain Monte
Carlo Methods (MCMC) programmed in R, a statistical
computing system freely available on the internet. We
provide the program code in an Additional File. This
may help a reader to understand the procedure in detail.
Methods
The cohort consisted of all male German blue-collar
workers who were continuously employed at the carbon
black production plant for at least one year between Jan
1
st 1960 and Dec 31
st 1998 and (1) whose mortality
could be followed beyond 1975; and (2) if deceased, died
from a known cause of death [6]. The cohort consisted
of 1528 carbon black workers and 25,681 person-years;
7 subjects with unknown cause of death were excluded.
In this cohort, 50 subjects died of lung cancer. This
Bayesian analysis focused on the SMR findings of the
national reference rates to avoid over-adjustment due to
differences in smoking behaviour between West-Ger-
many and the state North-Rhine Westphalia. We there-
fore based all adjustment procedures on the higher lung
cancer SMR estimate of 2.18 (0.95-CI: 1.61, 2.87)
reported in the first cohort analysis [6].
The Bayesian adjustment procedure followed an out-
line proposed by Steenland and Greenland [12], includ-
ing how to structure a Bayesian model of unmeasured
or only partly measured confounders, and how to derive
an adjusted posterior SMR after applying all available
background information. A posterior SMR is a term
used in Bayesian analysis that includes both, a priori
knowledge about the parameter that models the unmea-
sured or partly measured confounding and the standard
frequentist statistical assessment.
Frequentist methodology assumes that parameters are
fixed and that the observed data were realized from a
probability distribution given the parameters. This dis-
tribution is described by the likelihood function, P(data
| parameters), i.e., the probability of the data given the
parameters. Frequentists usually base their conclusions
only on this function and the observed data. In contrast,
a central idea of Bayesian thinking is that parameters
are uncertain. First, this uncertainty obviously exists at
the beginning of all discussions and research. Second,
this uncertainty about parameters cannot be removed by
new data totally - but the degree of uncertainty can be
modified in the light of new data. Bayesian theory quan-
tifies the knowledge and uncertainty we begin with in
terms of a prior distribution of the parameters, P (para-
meters). In subjective Bayesian theory this first input to
the analysis describes how the analyst would bet about
the parameters if the data under analysis were ignored.
The likelihood function - as used by the frequentists - is
the second input to the Bayesian analysis. It describes
the probability the analyst would assign to the observed
data given the parameters. How to move forward from
here? Basic rules of probability theory imply the Baye-
sian theorem. This theorem says
P parameters data P data parameters P parameters P data (| ) ( |) () / ( ) = . .
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our knowledge and degree of uncertainty about the
parameters after we have analyzed the observed data.
The goal of the analysis is to calculate how we should
bet about the parameters after the data was observed
and analyzed. Therefore, we are interested in P(para-
meters | data), that is the posterior distribution of the
parameters. The factor 1/P(data) is often called the pro-
portionality factor and this factor links the posterior
with the product of likelihood and prior. The para-
meters that occur in the problem may be split into tar-
get parameters and bias parameters. What we are really
interested in are the target parameters, like the SMR.
But bias parameters may have distorted the data we
observed to learn about the target. The distribution of
both kinds of parameters can be updated with the help
of the Bayesian theorem. The posterior target para-
meters, we are mainly interested in, are the adjusted tar-
get parameters taking the distribution of bias
parameters, our prior knowledge about the target para-
meters and the observed data into account. In summary,
Bayesian bias analysis offers an analysis that adjusts the
SMR (= target parameter) and estimates the uncertainty
of the SMR by including a quantitative assessment of
the effect of bias, and in particular, confounding, on the
results. We provide a glossary of key terms used in this
article in Additional File 1.
How are results reported? The central tendency
("point estimate”) is often described by the median of
the posterior distribution (e.g., [12]) because the median
is not as vulnerable to skewness and extreme values in
the empirical posterior distribution as the mean [13].
The degree of uncertainty ("interval estimate”)i so f t e n
reported as the central 95% region of the posterior dis-
tribution and is called 95% posterior interval or 95%
Bayesian interval ([9], p. 332, 379) or 95% highest den-
sity region or 95% credible interval ([14], p.49). The lat-
ter name points to an important distinction: whereas
the 95% posterior interval can be validly interpreted like
“Given these prior, likelihood, and data we would be
95% certain that the parameter is in this interval.” The
conventional 95% confidence interval has no such
appealing interpretation. The following difficult state-
ment is logically justified as an interpretation of conven-
tional 95% confidence intervals given a probability of 5%
is accepted as an indicator of “improbable": “If these
data had been generated from a randomized trial with
no drop-out or measurement error, these results would
be improbable were the null true.” ([9], p. 333). Note
that Rothman and colleagues added “but because they
were not so generated we can say little of their actual
significance”. Indeed, in observational epidemiology
there is no such data generating mechanism at work.
Thus, the Bayesian approach offers an advantage
because interval estimates can be interpreted in a
“natural” way.
As an introduction into Bayesian perspectives and
procedures, we refer to papers by Greenland [15,16] and
also suggest reading more detailed overviews of Bayesian
applications and philosophy [9,14,17,18]. An easy to
read but profound introduction into Bayesian statistics
was given by Greenland in chapter 18 of [9]. A good
overview of bias analysis in epidemiology was written by
Greenland and Lash (chapter 19 of [9]). An application
of Bayesian techniques in bias adjustment via data aug-
mentation and missing data methods was explained and
exercised in Greenland 2009 [11].
Although we followed the outline proposed by Steen-
land and Greenland 2004 [12] some notable differences
exist. An important extension in this analysis is that it
shows how to deal with more than just one uncontrolled
cause of bias. Steenland and Greenland 2004 [12]
adjusted for uncontrolled smoking with the help of
Bayesian methods. Here we adjusted for two bias fac-
tors, smoking and prior exposures experienced before
being hired at the carbon black plant. However, Steen-
land and Greenland 2004 [12] were able to use a three-
level smoking variable whereas we could only rely on
binary coded smoking data. More importantly, we exam-
ined the impact of different prior explications, in parti-
cular non-flat priors and of correlations between prior
parameters, which are topics not covered by Steenland
and Greenland 2004 [12]. For more details see the dis-
cussion section of this report.
The SMR as obtained in mortality studies is customa-
rily adjusted only for age, gender and calendar time. Con-
founding, such as cigarette smoking is not addressed.
Thus, the SMR is potentially biased. To adjust the SMR
for partly measured potential confounders like smoking,
we developed a likelihood of the outcome data. In this
study, the outcome data were simply the number of
observed cases (observed = 50 lung cancer deaths). This
number of observed cases depends on three values: a) the
number of expected cases, calculated with the help of
reference rates (expected = 22.9 lung cancer deaths), b)
the unbiased SMRtrue and c) the degree of bias.
Under usual assumptions [19] (customary frequentist
statistic) we can write
observed Poi expected SMR bias true ~( * * ) ,
Where Poi(l) denotes the Poisson distribution with
parameter l and * denotes multiplication.
This specifies the likelihood P(observed | expected,
SMR, bias). [Here and in the following we drop the
index “true” for the sake of simplicity.]
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sources (smoking and previous exposures, see Back-
ground section) and can be written [20]
bias bias bias smoke prev = *.
To explicate the likelihood we had to quantify the bias
components biassmoke and biasprev. We supposed that
biassmoke depends on three prior parameters
▪ propsmoke, pop : proportion of smokers/ex-smokers
in the general population
▪ propsmoke, coh : proportion of smokers/ex-smokers
in the carbon black cohort
▪ ORsmoke : odds ratio of lung cancer mortality for
smokers/ex-smokers vs. never smokers
and that the degree of bias could therefore be esti-
mated as
bias
propsmoke,coh*ORsmoke 1-propsmoke,coh
propsmoke,p
smoke =
+
o op*ORsmoke 1-propsmoke,pop +
.
The derivation of this formula is given in Additional
File 2. It is based on concepts developed and applied by
C o r n f i e l de ta l .1 9 5 9[ 2 1 ]( r e p r i n t e da sC o r n f i e l de ta l .
2009 [22]), Bross 1966 [23], Yanagawa 1984 [24] or
Axelson and Steenland 1988 [25].
A similar argument can be applied to estimate the bias
due to previous exposures (biasprev.) It depends on the
three prior parameters
▪ propprev, pop : proportion of subjects occupationally
exposed to crystalline silica in the general population
▪ propprev, coh : proportion of subjects previously
exposed to crystalline silica in the carbon black
cohort
▪ ORprev : odds ratio of lung cancer mortality for
previous exposure to crystalline silica
and can be calculated as
bias
propprev,coh*ORprev 1-propprev,coh
propprev,pop*OR
prev =
+
p prev 1-propprev,pop +
.
We derived a prior distribution for the three para-
meters defining the bias due to differences in the smok-
ing behaviour between cohort and population and we
derived a prior distribution for the three parameters
defining the bias due to differences in the exposure to
crystalline silica dust exposure between cohort and
population. This information was incorporated into the
likelihood so that the usual frequentist approach was
extended by the prior data. Defining and applying a full
distribution and not only a point estimate for, say,
propsmoke, coh has the advantage of taking the uncer-
tainty of this parameter estimate into account whereas
this uncertainty, although existing without doubt, is
usually ignored in a simple sensitivity analysis [5,26].
Firstly, we derived distributions for the proportion of
smokers in the cohort and in the population. We made
extensive use of the logit-function because it can be
readily applied to approximate distributions of propor-
tions by the Gaussian distribution [12]. The logit-
transformation is defined as logit x = log (x/(1-x)) with
log denoting the natural logarithm. We use N(μ,s
2)t o
denote the Gaussian distribution with mean μ and var-
iance s
2. An approximate distribution of a proportion p
can be described as follows [12]: If pobs denotes the
observed proportion among n subjects and p the ran-
dom variable realised as pobs we use logit (p) ~ N(μ,s
2)
as an excellent approximation with μ estimated by logit
pobs and s estimated by s = (pobs (1- pobs)n)
(-1/2).W e
applied this formula to data about the smoking preva-
lence in the cohort. We derived and used two candi-
dates for the distribution of p in the cohort, one based
on case-control information [8] about smoking and one
based on cohort information [5]. The proportion of sub-
jects acting as controls and classified as smokers or ex-
smokers in the nested case-control study group was 84%
[8] and the proportion of subjects in the cohort who
were classified accordingly was 83.95% [5]. Using these
percentages based on 48 control subjects in the case-
control study [8] and based on 1180 workers with smok-
ing information in the cohort study [5] we derived the
following two alternative priors, both estimating the
proportion of smokers in the cohort: (a) logit(0.84) =
1.66, s = (48*0.84*0.16)
(-1/2) =0 . 3 9 4 ,i . e . ,l o g i tp r o p smoke,
ncc ~ N(1.66, 0.394
2) using nested case-control informa-
tion, and (b) logit(0.84) = 1.66, s = (1180*0.84*0.16)
(-1/2)
= 0.0794, i.e., logit propsmoke, coh ~ N(1.66, 0.0794
2)
when applying cohort data. Next, we derived an approx-
imate distribution for the proportion of smokers in the
population. Given a proportion of 65% smokers among
males in West-Germany based on a representative sam-
ple of 3450 men [27,28] we calculated for the population
logit(0.65) = 0.619, s = (3450*0.65*0.35)
(-1/2) = 0.0357
and, therefore, set logit propsmoke, pop ~N( 0 . 6 2 ,
0.0357
2) accordingly.
Secondly, we derived a distribution of the effect of
smoking on lung cancer mortality. The conditional
logistic regression for lung cancer mortality depending
on a smoking indicator (active smokers/ex-smokers vs.
never smokers) yielded an odds ratio of ORsmoke =9 . 2 7
(0.95-CI: 1.16, 74.4) when analyzing the nested case-
control study [8]. Based on this information we esti-
mated log ORsmoke = 2.227 with a standard deviation of
ssmoke = log(74.4/1.16)/3.92 = 1.061, the latter calculated
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Gaussian approximation to log ORsmoke. Therefore, we
set log ORsmoke ~ N(2.23, 1.06
2) as the informative prior
about the effect of smoking in our cohort. This Gaus-
sian approximation holds because the log OR is identical
to the coefficient in the logistic regression model and
the coefficient is normally distributed according to max-
imum likelihood theory [19].
Next, we had to construct a prior distribution for the
three parameters defining biasprev. Again we made use of
the logit-approximation to derive a prior for the propor-
tions of subjects being exposed to silica. And again, as
with smoking, we derived two candidates for the distribu-
t i o no ft h ep r o p o r t i o ni nt h ec o h o r t ,o n eb a s e do na n
application of CAREX [29,30] which is a computer assisted
information system for the estimation of the numbers of
workers exposed to established and suspected carcinogens
and one based on an expert assessment. Büchte and co-
workers [8] applied the data of the CAREX system [29,30]
to derive automatic estimates of previous exposures within
the nested case-control: since 74% of the 88 workers (con-
trols) were identified as previously exposed we got logit
(7%) = 1.05 and s = (88*0.74*0.26)
(-1/2) = 0.2432. This lead
to a prior of logit propprev, coh ~ N(1.05, 0.243). This is the
“CAREX cohort prior”.
A brief description of the CAREX system [29,30] is
warranted. CAREX is a computer assisted information
system for the estimation of the numbers of workers
exposed to established and suspected human carcino-
gens in the member states of the European Union. This
system can be automatically applied to estimate the
probability of being exposed to a specific carcinogen.
Details of how it was used in this study are given else-
where [8]. CAREX is based on information about occu-
pational exposure in 1990 to 1993 estimated in two
phases. Firstly, estimates were generated on the basis of
Finnish labour force data and exposure prevalence esti-
mates from two reference countries (Finland and the
United States) which had the most comprehensive data
available on exposures to these agents. For selected
countries, these estimates were then refined by national
experts in view of the perceived exposure patterns in
their own countries compared with those of the refer-
ence countries.
Blinded to the CAREX system [29] data and to the
case-control status, a German occupational-exposure
expert independently assessed whether the study mem-
bers of the case-control study were exposed to occupa-
tional carcinogens before being hired at the carbon
black plant [8]: since 16% of the 88 workers (controls)
were documented as exposed by this expert, we derived
logit (16%) = -1.66, s = (88*0.16*0.84)
(-1/2) =0 . 2 9 1 2a n d
therefore got a second prior suggestion: logitprev, coh ~
N(-1.16, 0.291). This is the “expert cohort prior”.
In the next step, we derived an approximate distribu-
tion of the percentage of male workers exposed to crys-
talline silica in the population. Whereas we defined just
one prior for the percentage of smokers in the popula-
tion the situation is more complicated with silica dust
exposure. We derived two main candidates for the prior
and two further candidates used in an additional sensi-
tivity analysis. Based again on the CAREX system [29]
the percentage of male workers occupationally exposed
to crystalline silica in the population was estimated as
2.3%. We set logit (2.3%) = -3.74, 0.95-CI: 2.3%/2, 2.3%
*2, i.e., s = 0.3536 and therefore logitprev, pop ~ N(-3.74,
0.3536). This is the “CAREX population prior”. Here we
assumed implicitly that the CAREX estimate is unstable
by a factor of two. Since the German expert did not
assess the degree of crystalline silica exposure of the
male population, we proceeded as follows. The expert
documented 16% of the controls being exposed but the
CAREX system [29] estimated 74%. We used the ratio
of these percentages to adjust the CAREX estimate of
the population prevalence accordingly: 16/74*2.3% =
0.5%, and we set logit (0.5%) = -5.30, 0.95-CI: 0.5%/2,
0.5%*2, i.e., s = 0.3536 which leads to logitprev, pop ~N
(-5.30, 0.3536). This is the “expert population prior”.
This was used as the main population prior in the calcula-
tion based on the German expert’sd a t a .B e c a u s et h i sp r i o r
appears to be difficult to justify as a reliable description of
the crystalline silica dust exposure distribution in the
population (based on the expert’s opinion) we repeated
the analysis while assuming a prior with a larger spread
(corresponding to a factor of 5): logitprev, pop ~ N(-5.30,
0.8211). Note that log(5)/1.96 = 0.8211. In addition we
used a prior with an expectation equal to the “CAREX
population prior” but accompanied with a larger spread
(again corresponding to a factor of 5): logitprev, pop ~N
(-3.74, 0.8211). These different priors (one main and two
further candidate “expert population priors”) were used to
study the sensitivity of the results due to our missing
knowledge about the prevalence of crystalline silica dust
exposure in the population if the expert had estimated it.
Finally, we needed an estimate of the effect of pre-
vious silica dust exposure on lung cancer risk. Again we
derived two explications, one based on the CAREX
[29,30] data and the other based on the expert’s assess-
ment. Analyzing the nested case-control study by condi-
tional logistic regression yielded a smoking adjusted OR
= 2.1 (0.95-CI = 0.39, 11.2) for the CAREX based indi-
cator of being previously exposed to crystalline silica [8].
This lead to log OR = 0.74, s = log(11.2/0.39)/3.92 =
0.8565 and, thus, we derived as the prior log ORprev, coh
~ N(0.74, 0.857). This is the “CAREX effect prior”.
Based on the German expert’s data, the OR for previous
exposures was estimated as 5.06 (0.95-CI= 1.68, 15.27).
Applying a conservative correction for smoking [6,8] we
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(5.06*2.04/3.28) = 1.146, s = log(15.27/1.68)/3.92 =
0.5632 and set log ORprev, pop ~ N(1.15, 0.563) as the
prior. This is the “expert effect prior”.
Because we did not think it appropriate to rely on a
single overall prior that may not be able to represent all
available prior knowledge, we derived instead different
explications of biassmoke and biasprev as outlined above
and used these explications in sensible combinations to
derive four main Bayesian analyses. The structure of this
approach is summarized in Table 1.
Given the likelihood of the data P (observed |
expected, SMR, bias) as explicated we calculated an
adjusted (posterior) SMR by Bayes’ theorem after insert-
ing the bias priors derived above. However, to apply the
theorem, it was also necessary to insert an appropriate
prior distribution for the true SMR.
We followed Steenland and Greenland [12] and used
an uninformative, flat prior P (SMR) specified by
log ~ ( , ) . SMR N 0 10
8
Here log denotes again the natural logarithm and N(μ,
s
2) the Gaussian distribution with mean μ and variance
s
2.
The adjusted SMR is given by the posterior distribu-
tion P (SMR|observed) that now can be derived with the
help of Bayes’ theorem as
P SMR bias observed factor P observed expected SMR bias (,| ) * ( | ,,) * = P PS M Rb i a s (,) .
Integrating over the bias in P (SMR, bias | observed)
gives the marginal distribution of the posterior SMR
we were interested in mainly. Unfortunately, the calcu-
lation is often difficult and usually no closed analytical
solution in elementary functions exists. In particular,
the proportionality factor is difficult to determine.
However, a numerical solution is possible using a Mar-
kov Chain Monte Carlo (MCMC) simulation approach
[31]. In particular, the posterior can be estimated by
MCMC without knowing or calculating the standardiz-
ing factor. Concept and proof of this approach were
developed and given by Metropolis and co-workers
[32] and Hastings [33]. Here we applied a Metropolis’
Gaussian random walk generator following the imple-
mentation instructions given by Newman [34]. All
prior distributions were assumed to be independent.
We chose a burn-in phase of 50,000 cycles and evalu-
ated the Markov chain over a length of 1,000,000. We
tuned the random walk parameters (s’s of the Gaus-
sian proposal distribution) in such a way that the
acceptance rate was between 20% and 40% for all para-
meters estimated [31].
We plotted the trace for all parameters as simple diag-
nostic tools informing about goodness of sampler con-
vergence. An introduction to trace plots is given in the
Statistical Analysis System (SAS) documentation [35].
A l la n a l y s e sw e r ed o n ew i t ht h eRp a c k a g e[ 3 6 ] .T h e
program doing Analysis 1 (see Table 1 for definition) is
given in Additional File 3.
Table 1 Gaussian prior distributions (mean μ and standard deviation s) applied in the four analyses.
Analysis
CAREX Expert
smoking cohort smoking case-control smoking cohort smoking case-control
1234
μ s μ s μ s μ s
Effect
log OR smoke 2.23 1.06 2.23 1.06 2.23 1.06 2.23 1.06
log OR prev 0.74 0.857 0.74 0.857 1.15 0.563 1.15 0.563
Proportions
logit prop smoke, pop 0.62 0.0357 0.62 0.0357 0.62 0.0357 0.62 0.0357
logit prop smoke, coh 1.66 0.0794 1.66 0.394 1.66 0.0794 1.66 0.394
logit prop prev, pop -3.74 0.366 -3.74 0.366 -5.30 0.356 -5.30 0.356
logit prop prev, coh 1.05 0.243 1.05 0.243 -1.16 0.291 -1.16 0.291
One effect specification was used throughout to describe the prior for smoking (log ORsmoke). Two effect specifications were applied to estimate the effect of
previous exposures (log ORprev): one was based on CAREX data (Analyses 1 and 2) and a second based on data assessed by a German expert (Analyses 3 and 4).
The proportion of male smokers in the population was estimated in all analyses by a representative sample from the male population (logit propsmoke, pop). Two
estimates were derived for the cohort percentage (logit propsmoke, coh): one based on cohort data (Analyses 1 and 3) and a second based on case-control
information (Analyses 2 and 4). The prevalence of previous occupational exposure to crystalline silica (logit propprev, pop) was estimated by the CAREX system
(Analyses 1 and 2) or adapted to fit to the German’s expert data (Analyses 3 and 4). The proportion of silica exposed males in the cohort (logit propprev, coh)w a s
derived from CAREX data (Analyses 1 and 2) or from assessments of the German expert (Analyses 3 and 4). For the SMR we always used a flat prior: log SMR ~ N
(0,10
8).
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The distribution of the adjusted lung cancer SMR pro-
duced by Analysis 1 (see Table 1 for definition) is
shown in Figure 1. The MCMC random walk generated
a wide spread of posterior SMR (adjusted SMR) values
with half of the estimates below the reference point of 1.
An overview of the results from all four analyses is
given in Table 2.
Analysis 2 resulted in almost exactly the same findings
from Analysis 1. Very similar results were produced also
by Analyses 3 and 4. Therefore, it made no relevant dif-
ference whether the bias adjustment was based on
Figure 1 Distribution of the posterior lung cancer SMR based an Analysis 1 (see Table 1): previous exposures estimated by the CAREX
method, smoking estimates based on cohort data. Results from an MCMC random walk of length 1,000,000 (Metropolis sampler). The x-axis
stretches to the maximum of 10.7. Other characteristics of this empirical posterior distribution are given in Table 2.
Table 2 Characteristic statistics of the posterior lung cancer SMR distribution, i.e., the distribution of the bias adjusted
SMR.
Analysis
CAREX Expert
smoking cohort smoking case-control smoking cohort smoking case-control
1234
SMR, posterior
median 1.00 1.01 1.32 1.32
arithmetic mean 1.21 1.22 1.33 1.34
standard deviation 0.82 0.83 0.34 0.35
2.5%-fractile 0.24 0.25 0.70 0.70
97.5%-fractile 3.31 3.37 2.04 2.07
Findings are reported according to the four analyses described in Table 1.
The number of significant digits displayed is for comparison purposes only. The data set is not of sufficient size to support this accuracy.
Results from MCMC random walks (Metropolis sampler) of length 1,000,000.
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Page 7 of 14smoking data from the cohort (Analyses 1 and 3) or on
the information gained from the nested case-control
study (Analyses 2 and 4). [This similarity of findings is
somewhat expected because the competing analyses
involve inflating the prior variance of the proportion of
smokers in the cohort This should not affect results
substantially because it is the prior mean of the bias
parameters that dictates the magnitude of unmeasured
confounding.] Lower posterior SMRs were calculated
when using the automatic previous exposure assessment
by the CAREX approach (Analysis 1 and 2): median
adjusted SMRs were found at 1, arithmetic averages at
about 1.2. The posterior lung cancer SMR estimates
showed a median and mean of about 1.3 when using
expert data. The analysis based on the CAREX data pro-
duced a wider range of bias adjusted estimates (95%
posterior interval: 0.2, 3.4) than the findings from the
Bayesian analyses when applying the expert’s assessment
(95% posterior interval: 0.7, 2.1).
We performed two additional analyses with the expert’s
data applying a larger spread to the prior distribution of
crystalline silica exposure in the population. Firstly, we
assumed logitprev, pop ~ N(-5.30, 0.8211) which corre-
sponds to the expert’s prior as before but with an uncer-
tainty factor of five instead of two. The posterior SMR
was estimated at 1.32 with a 95% posterior interval span-
ning from 0.7 to 2.0. Secondly, we used a prior with an
expectation equal to the CAREX prior but accompanied
with a larger spread (again corresponding to a factor of
5): logitprev, pop ~ N(-3.74, 0.8211). In this case, the pos-
terior SMR based on expert data was estimated as 1.40,
95% posterior interval = 0.8, 2.1.
In these analyses we always used a flat prior for the
SMR. We explored the robust n e s so ft h i sa p p r o a c hb y
applying more concentrated SMR priors. Following [9],
p. 334, 336 we used alternate prior distributions for the
SMR with 95% prior intervals spanning from 0.1 to 10
(corresponding to s = log(10)/1.96 = 1.175 for log SMR)
and 0.25 to 4 (corresponding to s = log(4)/1.96 = 0.707).
The standard deviations are clearly smaller than 10,000
we used in the main analyses. Based on the automatic
approach (CAREX, Analysis 1) we estimated 95% poster-
ior intervals spanning from 0.3 to 3.0 (s = 1.175) and 0.4
to 2.6 (s = 0.707), Analyses applying the expert data
(Analysis 3) returned 95% posterior intervals of 0.7 to 2.0
(s =1 . 1 7 5a n ds = 0.707), as expected, the medians of
the posterior distributions remained unchanged, i.e., they
were identical to those returned by the main analyses.
Additionally we explored whether a different specifica-
tion of the relative lung canc e rr i s ko fs m o k e r s / e x - s m o -
kers may affect the results considerably. We averaged
(geometric mean) estimates for men (active and ex-smo-
kers) from the Nationwide American Cancer Society pro-
spective cohort study ([37], Table Three, full models for
lung cancer) and used RR = 13.3 with 0.95-confidence
limits at 11.0 and 16.0. Applying the alternate prior dis-
tribution for the SMR with 95% prior intervals spanning
from 0.25 to 4 again, the analyses based on the smoking
effect estimates of Thun et al. 2000 [37] returned a med-
ian posterior SMR of 1.0 with a 95% posterior interval
spanning from 0.4 to 2.5 (CAREX, Analysis 1) and 1.3
(0.7, 1.9) when using expert data (Analysis 3).
Furthermore, we rerun these analyses while incorpor-
ating positive correlations between the draws of smok-
ing prevalences among cohort and population and
between the draws of silica exposure prevalences among
cohort and population. It may be argued that one
expects a higher prevalence among the cohort if the pre-
valence is higher in the population ([9], p. 371, 372). We
implemented these dependencies by applying formula
19-20 in [9], p. 372, and set both correlations between
the logits of prevalences to 0.8 (cp. [9], p. 374). The
modified Analysis 1 (CAREX) returned a median poster-
ior SMR of 1.0 with 95% posterior intervals spanning
from 0.4 to 2.6. The results were 1.3 (0.7, 1.9) when rea-
nalysing the expert data (Analysis 3).
As simple diagnostic tools informing about goodness of
sampler convergence we give trace plots for, e.g., the esti-
mated log SMR (= beta) and the estimated logit of pro-
portion of current or former smokers among unexposed
to carbon black (= xsm_nexp) in Analysis 1 (Figure 2)
and the logit of proportion of current or former smokers
among exposed to carbon black (= xsm_exp) and the
logit of proportion of previously exposed to crystalline
silica among exposed to carbon black (= xpq_exp) in
Analysis 4 (Figure 3). The names correspond to variable
names as used in the R program doing the analysis (see
Additional File 3). All the other estimated parameters in
all four analyses showed a similar behaviour as in the
examples presented in Figures 2 and 3.
Discussion
We applied a Bayesian methodology in a cohort study of
German carbon black production workers [6] to adjust
the elevated lung cancer SMR of 2.18 (0.95-CI: 1.61,
2.87) for potential confounding. A nested case-control
study had identified smoking and previous occupational
exposures to lung carcinogens received previous to work
at the carbon black plant as potential confounders [8].
We used a Markov Chain Monte Carlo approach
(Metropolis sampler) to quantify the effect of the poten-
tial confounders on the SMR by calculating the distribu-
tion of the posterior SMR[32,33].
The realized acceptance rates between 20% and 40%
were well in the range of published recommendations
[31] and trace plots revealed no problems with the con-
vergence behaviour of the MCMC sampler. Thus, the
chosen tuning parameters and sampler length of
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Page 8 of 141,000,000 appear to be appropriate together with a
burn-in phase of 50,000 cycles. Even such long Markov
chains could be realized and evaluated with the R pack-
age [36] on usual laptops or PCs with run times of only
a few minutes (programming code in Additional File 3).
The Bayesian analysis returned a median posterior
SMR estimate in the range between 1.32 (central 0.95-
region: 0.7, 2.1) and 1.00 (central 0.95-region: 0.2, 3.3)
depending on how previous exposures were assessed.
The first result is based on an independent expert
assessment of previous exposures combined with a con-
servative adjustment for smoking [5]. The second find-
ing is based on an automatic approach (CAREX)
[29,30]. The usually calculated lung cancer SMR statistic
overestimated effect and precision when compared with
the results from the Bayesian approach. This is particu-
larly true when the automatic approach (CAREX)
[29,30] was chosen to assess previous exposures. The
difference in point estimates between both approaches
resulted, at least in part, from the conservative handling
of the smoking adjustment within the first approach.
Additional analyses showed that the results based on the
expert’s assessments of prior silica dust exposure among
the carbon black workers changed only slightly when
the prior of the silica dust exposure distribution in the
population was varied.
The CAREX system [29,30] was applied to derive esti-
mates for crystalline silica exposure. Obviously, CAREX
may give distorted estimates when applied to a specific
group of workers [30]. Although the estimated level of
exposure may be distorted, there is no reason to suspect
a differential misclassification between cases and con-
trols stemming from the same cohort. To validate analy-
tical results based on CAREX estimates we used
estimates of exposure probabilities generated by an
independent German expert [8]. Again, we do not see a
reason to believe in a differential misclassification of
exposures between cases and controls. Because these
approaches are very different we were not surprised get-
ting clearly discrepant estimates of the prevalence of
workers previously exposed to crystalline silica dust in
the carbon black cohort: 74% (CAREX) versus 16%
(expert). However, both very different approaches led to
t h es a m ec o n c l u s i o n :t h ep r e v i o u se x p o s u r et oc a r c i n o -
gens received outside the carbon black plant, indicated
by exposure to crystalline silica dust, clearly biased the
Figure 2 Trace plots of log SMR (= beta) and the estimated
logit of proportion of current or former smokers among
unexposed to carbon black (= xsm_nexp). Names (beta,
xsm_nexp) correspond to the variable names used in the R
program (see Additional File 3). Results from an MCMC random
walk of length 1,000,000 (Metropolis sampler) in Analysis 1 (CAREX,
cohort smoking data). Plots include the burn-in phase of 50,000
cycles to give a complete graphical impression of the convergence
behaviour of the Markov chain (Time measures 1,050,000 cycles).
Figure 3 Trace plots of logit of proportion of current or former
smokers among exposed to carbon black (= xsm_exp) and
logit of proportion of previously exposed to crystalline silica
among exposed to carbon black (= xpq_exp). Names (xsm_exp,
xpq_exp) correspond to the variable names used in the R program
(see Additional File 3). Results from an MCMC random walk of
length 1,000,000 (Metropolis sampler) in Analysis 4 (expert’s
assessment, case-control smoking data). Plots include the burn-in
phase of 50,000 cycles to give a complete graphical impression of
the convergence behaviour of the Markov chain (Time measures
1,050,000 cycles).
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Page 9 of 14lung cancer SMR upwards. Thus, both very different
exposure estimation approaches led to similar quantita-
tive corrections of the potentially biased SMR. This con-
sistency is a strength and not a weakness of our
Bayesian bias adjustment procedure.
These findings partially support the results from sim-
ple sensitivity analyses. A corrected lung cancer SMR
was calculated as 1.33 (adjusted 0.95-CI: 0.98, 1.77)
when virtually the same bias adjustments were made
but with the naïve procedures as applied in our earlier
analysis. The derived bias factor depended in the same
degree on smoking and on previous exposures, each
relative bias was estimated to be about 25%. No uncer-
tainties of the bias parameters were taken into account
in that report [5]. As expected, uncertainty was inappro-
priately considered in the simple analysis although the
downward adjusted point estimate correctly conveyed
the large impact of the two biases.
SMR analyses have often been described as prone to
bias [38]. Researchers have been encouraged to consider
and quantify the potential distortions or to apply alter-
native analytical procedures. A discussion of these
described limitations of SMR analyses was given by
Morfeld and co-workers [5]. The degree of adjustment
derived in this study may appear surprisingly large in
comparison to discussions of the impact of biases in
occupational epidemiology [39]. However, appropriate
simulation studies showed that a doubling of the relative
risk estimate may easily be produced in realistic epide-
miologic scenarios as a result of residual and unmea-
sured confounding [40].
C r y s t a l l i n es i l i c ad u s te x p o s u r ei so n l yaw e a kl u n g
carcinogen [41]. Elevated lung cancer mortalities were
observed [41] at cumulative exposures as high as 6
mg*m
3-years or even higher [42] and relative risks were
reported to be lower than 1.3 usually. The excess risk
appears to be concentrated on people with silicosis who
showed a doubled lung cancer mortality in comparison
to the general population [43]. However, in our nested
case-control study [8] the variable indicating previous
exposure to crystalline silica dust was found to be signif-
icantly linked to lung cancer mortality with odds ratios
of about 2 or 3 after adjustment for smoking and carbon
black exposure. The lower estimate was based on
CAREX data, the higher one on the expert’s assessment.
Thus, both approaches that we applied to estimate pre-
vious exposures to carcinogens resulted in clearly ele-
vated relative risk estimates - although the previous
exposure assessment approaches were independent and
very different in nature. It is important to note that
crystalline silica dust exposure was clearly correlated in
this study with other previous exposures to carcinogens,
like asbestos and PAH exposures. Thus, we interpreted
the crystalline silica dust exposure variable as an
indicator of exposure to a combination of carcinogens
received outside the carbon black plant [8]. We did not
use external relative risk data to adjust for the potential
impact of previous exposures to crystalline silica dust in
this study because partial data on confounders were
available for the cohort of interest. Data describing the
risk situation of the cohort are usually preferred in
adjustment compared to external data because no addi-
tional exchangeability assumption must be accepted. It
is unusual, for example, to adjust for age in a study by
using population data on lung cancer age trends if an
internal adjustment is possible by the age data of the
cohort at hand. However, an external approach would
be the only way to adjust for confounders if no data on
covariate risk estimation were available for the cohort.
The latter argumentation applies also to smoking sta-
tus as cause of a potential bias in occupational lung can-
cer epidemiology. In this bias analysis we wanted to
exploit the gathered data about the workers under study
to the best of our ability. However, it is important to
note that additional external data about the effect of
smoking (e.g., [37], as applied to a US cohort of crystal-
line silica exposed workers by Steenland and Greenland
[12]) may help to yield narrower posterior intervals -
given that these data are truly applicable to the cohort
under study. A recent overview by the International
Agency for Research on Cancer (IARC) [44] showed a
large variation in lung cancer risk estimates between
investigations (Table 2.1.1.1) and the IARC working
group compiled evidence for factors affecting risk like
duration and intensity of smoking, type of cigarette, type
of inhalation, and population characteristics (gender,
ethnicity). The smoking stat u sv a r i a b l ea sd o c u m e n t e d
in this investigation and other epidemiological studies is
only a crude measure and may also code additional life
style and social class differences [45]. Thus it is not easy
to judge whether externally gathered data on the smok-
ing-lung cancer association do really apply - together
with their larger precision. We hesitated to do this in
the main analysis and decided to use only data in this
bias adjustment that was gathered for this cohort and
collected for the embedded case-control study. However,
we applied additionally relative risk estimates with 0.95-
confdence intervals based on the Nationwide American
Cancer Society prospective cohort study [37] to explore
the impact of the somewhat higher point estimate and
the much smaller confidence interval on the bias correc-
tion. No substantial change in the posterior SMR esti-
mate was observed.
The analyses presented suffer from some uncertainties
not quantified. For example, our computations were
based on the assumption that the odds ratios from the
nested case-control study analyses estimated the relative
risks for the cohort in a suitable way and that the
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sure to crystalline silica was representative for the
cohort. Such an assumption may hold for the smoking
distribution although based on the sub-cohort with
smoking information only but can be questioned for
cumulative carbon black exposure [8]. Thus, the ques-
tion remains whether the controls were representative
for the previous exposure distribution among the cohort
members. Moreover, some distortions may be due to a
small sample bias [46], an argument relevant for the
analyses based on the expert assessment of the data. We
applied a conservative correction for smoking, as noted
in an earlier paper, to reduce this potential bias [8].
We applied crude estimates ("guessed factors”)t o
quantify the instability of CAREX percentages of occu-
pational crystalline silica exposure in the population and
used an additional adaptation factor to derive population
prevalence estimates for an analysis applying expert
assessment data. Although these factors could have been
varied in additional sensitivity analyses, we believe that
the uncertainty of these “guesses” is of minor impact on
the results because posterior SMRs showed a wide
spread and the performed sensitivity investigation on
the expert population prior returned no relevant impact
of the varied prior parameter values on the result.
Whether the derived prior distributions are indepen-
dent from one another is worthy of discussion. External
exposures and tobacco consumption showed some posi-
tive correlation [8], however, correction factors for pre-
vious exposures were derived after adjustment for
smoking. We therefore believe that the correction of the
SMR distortion attributed to previous exposures is inde-
pendent of the bias correction due to the differing
smoking behaviour in the cohort and the population. A
further assumption made is that the confounding biases
are independent of the confounding from measured
variables (like age and calendar time). However, our
ability to specify such correlations knowledgeably is
clearly limited and almost all bias analyses rely on this
assumption (e.g., [12,13,47], see chapter 19 of [9]). How-
ever, implementing correlations of 0.8 between the
draws of the logit of smoking prevalences among cohort
and population and between the draws of the logit of
crystalline silica prevalences among cohort and popula-
tion did change the results only negligibly.
A possible distortion due to a healthy worker survivor
bias cannot be ruled out. However, in Cox analyses of
this cohort it was tried to separate out past aspects of
exposure to adjust for survivor biases [7]. This approach
is not fully appropriate. A far better and more valid
adjustment can be performed by G-estimation [48-51].
However, a considerable amount of detailed longitudinal
data is necessary to generate enough power if that pro-
cedure is applied [52]. Due to the severe power
restriction in this study (only 50 lung cancer deaths
available) an application of Robins’ G-estimation will be
to no avail. Thus, distortions due to possible survivor
selection effects are not satisfactorily resolved.
We followed Steenland and Greenland [12] and applied
like de Vocht and co-workers [13] an uninformative prior
for the SMR. Strictly speaking, such priors are strange
because extremely high and extremely low relative risks
a r eg i v e nt h es a m ep r o b a b i l i t ya sr e l a t i v er i s k si na“nor-
mal” range between 0.25 and 4 [18,53]. Thus, it is indi-
cated to apply an informative prior that is more realistic
[9,54]. However, the prior should be “broad enough to
assign relatively high probability to each discussant’s opi-
nion” [15]. A possible occupational cancer risk due to
carbon black exposure is indicated by the occurrence of
lung cancer in rats after inhalation or instillation of car-
bon black and, thus, a working group at the International
Agency for Research on Cancer concluded that there is
sufficient evidence in experimental animals for the carci-
nogenicity of carbon black and carbon black extracts [4].
However, Valberg and co-workers [55] summarized their
overview on the carcinogenicity of carbon black as fol-
lows: “new epidemiological evidence decreases concerns
for cancer risks compared with the pre-1996 evidence.
Laboratory studies support a conclusion that the
mechanism of tumorigenicity of CB [carbon black] in
rats is no different from that of any poorly soluble parti-
cles, ie, toxicity results from the particle overload per se,
and not from the particles’ chemistry”. A leading working
group in particle toxicology concluded [56] that the
observed carcinogenic effect of carbon black is only spe-
cific for rats and that the effects cannot be demonstrated
in mice or hamsters. Moreover, they proposed a thresh-
old effect in rats implying that no cancer hazard exists in
rats (and humans) if exposures are controlled accord-
ingly. This judgement of a limited relevance of the posi-
tive rat experiments with poorly soluble particles is in
line with the consensus report of an expert workshop
held at the ILSI institute [57]. Thus, we think it appropri-
ate to apply a flat prior to the SMR in this analysis cover-
ing without doubt all these opinions about the potential
carcinogenicity of carbon black. Like Steenland and
Greenland [12] we do not think that is a major drawback
to include absurd large and small priors also. The applied
flat SMR prior distribution may help to convince scien-
tists from other faculties not acquainted with Bayesian
thinking that such a bias analysis is a worthwhile exercise
- or even may convince frequentists who resist to a non-
flat prior distribution of the target parameter [58].
However, we explored the robustness of our findings
by applying more concentrated SMR priors. Alternate
prior distributions for the SMR with 95% prior intervals
spanning from 0.1 to 10 and 0.25 to 4 produced some-
what narrower interval estimates. The main effect was a
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lyses. These results did not indicate that the main ana-
lyses based on flat priors for the SMR were misleading.
Our finding that the elevated lung cancer SMR in the
German study cannot be taken as proof for a causal
impact of carbon black exposure on lung cancer risk is
consistent with the recent decision of an IARC working
group to classify carbon black - based on positive find-
ings in rat experiments - as Group 2B ("possibly carci-
nogenic”) but not as a human lung carcinogen [4]. The
working group stated that “there is inadequate evidence
in humans for the carcinogenicity of carbon black” [4].
Further support of this decision was given by an
updated analysis of two large case-control studies in
Montreal: “Subjects with occupational exposure to car-
bon black... did not experience any detectable excess
risk of lung cancer” [59].
Bayesian bias analyses - and to a lesser extent, as an
approximation, Monte Carlo sensitivity analyses - are
recommended for combining background data about
biases from different sources [12] p.385, [60] p.47, [9]
p.378-380. In contrast to Monte Carlo Sensitivity Ana-
lyses the Bayesian method follows a clear mathematical
and philosophical rationale [10], [60] p.53; chapter 18 of
[9], [17]. The Bayesian approach can take into account
correlations between multiple bias estimates and their
different precisions [11]. Even crude estimates of the
probable degree of distortion can be included. This
method is especially valuable when observational studies
are performed with a large number of subjects (high
precision) to quantify small effects sizes (low risk) as
often in genetic or environmental epidemiology [61].
Bayesian analyses may also help to cope with inflated
associations [61]. Overstated effect estimates are to be
expected even if the study is unbiased in the usual sense
[62]. Other authors have also noted the value of Baye-
sian analyses, e.g., to reduce false positives in epidemiol-
ogy [63]. Bayesian false discovery probability is also
currently used in the analysis of large genetic data bases
where the danger is rather large that conventional analy-
tical analyses label spurious associations as noteworthy
[64]. Another important application is smoothing by
hierarchical Bayesian models [65]. Markov Chain Monte
Carlo Methods (MCMC) can be used in these analyses
and to perform a Bayesian bias correction, the objective
of this paper, in simple and complicated scenarios [31].
Programming can be done with standard software
packages like the R program [36]. Other recent applica-
tions of Bayesian methods for correcting unmeasured
confounding [13] and misclassification [66] in epidemio-
logical studies are promising examples that this analyti-
cal technique may become a common tool in
epidemiology. Thus, Bayesian bias adjustment can
become a valuable adjunct in occupational and
environmental epidemiology to overcome narrative dis-
cussions of potential distortions.
Conclusions
Bayesian bias adjustment is an excellent tool to quanti-
tatively combine data about confounders from different
sources. Markov Chain Monte Carlo Methods (MCMC)
can be used to evaluate Bayes’ theorem even in compli-
cated scenarios. Programming can be done with stan-
dard software like R that is readily available on the web.
Thus, Bayesian bias adjustment can become a regular
tool in occupational and environmental epidemiology to
overcome narrative discussions of potential distortions.
We studied a statistically elevated lung cancer SMR of
2.18 (0.95-CI: 1.61, 2.87) in a German carbon black pro-
duction worker cohort with Bayesian techniques. No link
with carbon black exposure in internal analyses was
noted; potential confounders such as smoking and pre-
vious occupational exposures to carcinogens identified by
a nested case-control study showed that the normally cal-
culated lung cancer SMR overestimated effect and preci-
sion when compared with the MCMC results [median
posterior SMR estimate in the range between 1.32 (cen-
tral 0.95-region: 0.7, 2.1) and 1.00 (central 0.95-region:
0.2, 3.3) depending on the method how previous expo-
sures were assessed]. This finding is consistent with the
conclusion of an IARC working group in 2006 not to
classify carbon black as a human lung carcinogen.
Additional material
Additional file 1: Glossary of key terms. Key terms of the Bayesian
analysis and its implementation are explained.
Additional file 2: Derivation of the bias factor. The bias factor
equation is explained in detail which is applied throughout in the
analyses.
Additional file 3: R program code. R program for Bayesian bias
adjustment of a potentially distorted SMR via Markov Chain Monte Carlo
simulation (Metropolis sampler).
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